K., Katzman, D
Authored by: Sergey Terushkin, MD, FACS Last Updated: March 18, 2026 Storing medications like Ozempic, Wegovy, Mounjaro, and Zepbound in Florida takes extra care
Description Retatrutide 10mg Triple Agonist (GLP-1/GIP/Glucagon) Research Peptide Retatrutide is a synthetic triple receptor agonist activating GLP-1, GIP, and glucagon receptors simultaneously, studied as a next-generation metabolic research compound
So instead of focusing on how GLP-1 RAs might affect each individual electrolyte, a more helpful approach is to understand what complications might arise from GLP-1 usage and when they warrant attention
Currently approved UK weight management options include semaglutide (Wegovy) and tirzepatide (Mounjaro), subject to NICE Technology Appraisal eligibility criteria